They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Described as the “King Kong” of weight-loss drugs, Mounjaro – or tirzepatide – is an increasingly popular treatment that, while primarily designed to treat those with type 2 diabetes, has been ...

Ozempic is the weekly injection, commonly used to help lower blood sugar levels in people with type 2 diabetes. It is used to lower the risk of heart attack, stroke, or death. Ozempic works to ...

The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...

Described as the “King Kong” of weight-loss drugs, Mounjaro – or tirzepatide – is an increasingly popular treatment that, while primarily designed to treat those with type 2 diabetes ...

As drugs like Ozempic and Wegovy keep flying off pharmacy shelves, more and more patients are ignoring manufacturers' and medical professionals' instructions by "microdosing" it. As the New York ...

At 40 weeks, the mean HbA1c level with Mounjaro at a dose of 5 mg, 10 mg, and 15 mg was reduced by 2.01%, 2.24%, and 2.30%, respectively, compared to a reduction of 1.86% with Ozempic 1 mg.

Mounjaro, a brand name for tirzepatide ... The new arrival comes amid a continuing shortage of Ozempic, which is licensed for the control of type 2 diabetes here, but has also been prescribed ...